Expert Opinion on Biological Therapy, Volume 18, Issue 12 (2018)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Biological Therapy, Volume 18, Issue 12 (2018)

See all volumes and issues
Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Volume 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Key Paper Evaluation

Article
Grasping at straws: the failure of solanezumab to modify mild Alzheimer’s disease
Sheila A. Doggrell
Pages: 1189-1192
Published online: 09 Nov 2018
AbstractforGrasping at straws: the failure of solanezumab to modify mild Alzheimer’s disease | Full Text | References | PDF (382.1 KB)
  • 273 Views
  • 14 CrossRef citations
  • 0Altmetric

Drug Evaluation

Article
Bimekizumab for the treatment of psoriatic disease
Nicola E. Natsis & Alice B. Gottlieb
Pages: 1193-1197
Published online: 23 Oct 2018
AbstractforBimekizumab for the treatment of psoriatic disease | Full Text | References | PDF (442.6 KB)
  • 665 Views
  • 15 CrossRef citations
  • 0Altmetric

Review

Review
Engineered oncolytic viruses to treat melanoma: where are we now and what comes next?
Luke D. Rothermel & Jonathan S. Zager
Pages: 1199-1207
Published online: 27 Nov 2018
AbstractforEngineered oncolytic viruses to treat melanoma: where are we now and what comes next? | Full Text | References | PDF (689.1 KB)
  • 450 Views
  • 16 CrossRef citations
  • 0Altmetric
Review
CD38 as an immunotherapeutic target in multiple myeloma
Francesca Bonello, Mattia D’Agostino, Maria Moscvin, Chiara Cerrato, Mario Boccadoro & Francesca Gay
Pages: 1209-1221
Published online: 13 Nov 2018
AbstractforCD38 as an immunotherapeutic target in multiple myeloma | Full Text | References | PDF (1.1 MB)
  • 743 Views
  • 24 CrossRef citations
  • 0Altmetric
Review
The immune microenvironment in vulvar (pre)cancer: review of literature and implications for immunotherapy
Ziena Abdulrahman, Kim E Kortekaas, Peggy J De Vos Van Steenwijk, Sjoerd H Van Der Burg & Mariette IE Van Poelgeest
Pages: 1223-1233
Published online: 02 Nov 2018
AbstractforThe immune microenvironment in vulvar (pre)cancer: review of literature and implications for immunotherapy | Full Text | References | PDF (1.1 MB)
  • 716 Views
  • 17 CrossRef citations
  • 0Altmetric
Review
Cell secretome based approaches in Parkinson’s disease regenerative medicine
Cláudia R. Marques, Ana Marote, Bárbara Mendes-Pinheiro, Fábio G. Teixeira & António J. Salgado
Pages: 1235-1245
Published online: 20 Nov 2018
AbstractforCell secretome based approaches in Parkinson’s disease regenerative medicine | Full Text | References | PDF (1 MB)
  • 261 Views
  • 19 CrossRef citations
  • 0Altmetric
Review
Respiratory syncytial virus vaccine: where are we now and what comes next?
Asif Noor & Leonard R. Krilov
Pages: 1247-1256
Published online: 14 Nov 2018
AbstractforRespiratory syncytial virus vaccine: where are we now and what comes next? | Full Text | References | PDF (914.8 KB)
  • 1000 Views
  • 22 CrossRef citations
  • 0Altmetric
Review
Diabetic retinopathy: a complex pathophysiology requiring novel therapeutic strategies
Michael Whitehead, Sanjeewa Wickremasinghe, Andrew Osborne, Peter Van Wijngaarden & Keith R. Martin
Pages: 1257-1270
Published online: 14 Nov 2018
AbstractforDiabetic retinopathy: a complex pathophysiology requiring novel therapeutic strategies | Full Text | References | PDF (1.3 MB)
  • 8824 Views
  • 105 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Wide variation in the use and understanding of therapeutic drug monitoring for anti-TNF agents in inflammatory bowel disease: an inexact science?
Mark A Samaan, Zehra Arkir, Tariq Ahmad & Peter M Irving
Pages: 1271-1279
Published online: 24 Oct 2018
AbstractforWide variation in the use and understanding of therapeutic drug monitoring for anti-TNF agents in inflammatory bowel disease: an inexact science? | Full Text | References | PDF (967.1 KB) | Supplemental
  • 307 Views
  • 12 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Understanding patient variability to biologic treatments in inflammatory bowel disease
Ahmad Z Al Meslamani
Editorial | Published online: 24 May 2024
Free Access
Next-generation CD40 agonists for cancer immunotherapy
Hampus Andersson et al.
Review Article | Published online: 23 May 2024
Open Access
Non-TNF biologics and their biosimilars in rheumatoid arthritis
Tsz Ching Mok et al.
Review Article | Published online: 22 May 2024
Could siRNA therapeutics change the way we treat dyslipidemia?
Peter E. Penson et al.
Editorial | Published online: 22 May 2024
Free Access
View all latest articles